← Eichor
Study identifier: NCT02206841 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Establishment of NAFLD Cohort and Development of Fibrosis Markers

Condition: Fibrosis of Liver  ·  Sponsor: Seoul National University Boramae Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.

This description comes directly from the study's public registry record.

Talk to the study team

Won Kim, MD,PhD  ·  8228702233  ·  drwon1@snu.ac.kr

Saekyung Joo, MD  ·  821089619285  ·  joo.sammy@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul Metropolitan Government Seoul National UniversitySeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02206841